OOIR: Observatory of International Research

Papers

(The H4-Index of Progress in Retinal and Eye Research is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The neuroimmune interface in retinal regeneration	196
In vivo application of base and prime editing to treat inherited retinal diseases	179
Widefield OCT angiography	178
Cell identity changes in ocular surface Epithelia	159
Non-vasogenic cystoid maculopathies	145
Vogt-Koyanagi-Harada disease under the lens: Insights from multimodal ocular imaging	145
International consensuses and controversies on causes, diagnosis and management of diabetic macular edema (DME)	136
Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics	121
Animal models for the evaluation of retinal stem cell therapies	118
Editorial Board	110
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	109
Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation	108
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	101
Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy	95
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	92
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	91
Central serous chorioretinopathy: An evidence-based treatment guideline	89
Corneal stromal repair and regeneration	87
Myocilin misfolding and glaucoma: A 20-year update	84
Editorial Board	84
A paradigm shift in retinal detachment repair: The concept of integrity	84
Squishy matters – Corneal mechanobiology in health and disease	82
Homeostatic plasticity in the retina	80
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	78
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	78

Quantification of retinal microvascular imaging features from fundus photos in ocular and systemic disease: a framework for standardization	75
Risk factors, clinical features and treatment of Behçet's disease uveitis	74
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	71
Are Müller glial cells gatekeepers of neuroprotection and regeneration in age-related macular degeneration? Unraveling their roles in pathophysiology and therapeutic innovation	71
Cell fate decisions, transcription factors and signaling during early retinal development	70
Femtosecond lasers in ophthalmology: Mechanisms, clinical breakthroughs, and multidisciplinary frontiers	69
How gut microbiota may impact ocular surface homeostasis and related disorders	69
The retinal pigmentation pathway in human albinism: Not so black and white	65
Eye care adherence in pediatric and elderly: Understanding and addressing the challenges	64
RNA-targeting strategies as a platform for ocular gene therapy	63
Genetic architecture of congenital cataracts: correlation of pathogenic variants with morphology and clinical outcomes	60
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	59
Cellular component transfer between photoreceptor cells of the retina	57
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	57
Rhodopsin, light-sensor of vision	56
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	56
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	52
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	50
Optical coherence tomography angiography in diabetic retinopathy	49
Editorial Board	49
Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality	47
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	47
Regulation of lens water content: Effects on the physiological optics of the lens	47